Loading...
Santhera Pharmaceuticals Holding AG
SANN.SW•SIX
HealthcareBiotechnology
CHF13.86
CHF0.72(5.48%)
Santhera Pharmaceuticals Holding AG (SANN.SW) Financial Performance & Statements
Review Santhera Pharmaceuticals Holding AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-62.17%
↓ 62.17%
Operating Income Growth
-148.49%
↓ 148.49%
Net Income Growth
-176.62%
↓ 176.62%
Operating Cash Flow Growth
-175.16%
↓ 175.16%
Operating Margin
-85.20%
↓ 85.20%
Gross Margin
59.42%
↑ 59.42%
Net Profit Margin
-107.30%
↓ 107.30%
ROE
-110.82%
↓ 110.82%
ROIC
-31.34%
↓ 31.34%
Santhera Pharmaceuticals Holding AG (SANN.SW) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Santhera Pharmaceuticals Holding AG stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $25.003M | $14.11M | $99.44M | $49.72M |
| Cost of Revenue | $10.66M | $5.21M | $1.64M | $653500.00 |
| Gross Profit | $14.34M | $8.90M | $97.80M | $49.06M |
| Gross Profit Ratio | $0.57 | $0.63 | $0.98 | $0.99 |
| R&D Expenses | $12.70M | $13.77M | $8.93M | $4.46M |
| SG&A Expenses | $17.23M | $12.93M | $18.03M | $9.18M |
| Operating Expenses | $29.93M | $26.64M | $26.95M | $2.73M |
| Total Costs & Expenses | -$40.59M | $31.86M | $28.59M | $3.39M |
| Interest Income | $11.14M | $0.00 | $0.00 | $12.68M |
| Interest Expense | $16.14M | $0.00 | $25.36M | $0.00 |
| Depreciation & Amortization | $2.87M | $2.77M | $1.22M | $607500.00 |
| EBITDA | -$1.40M | -$14.97M | $92.75M | $36.32M |
| EBITDA Ratio | -$0.06 | -$1.06 | $0.72 | $0.73 |
| Operating Income | -$15.59M | -$17.74M | $70.85M | $35.71M |
| Operating Income Ratio | -$0.62 | -$1.26 | $0.71 | $0.72 |
| Other Income/Expenses (Net) | -$10.99M | $2.65M | $7.39M | -$5.45M |
| Income Before Tax | -$26.57M | -$15.09M | $78.24M | $39.12M |
| Income Before Tax Ratio | -$1.06 | -$1.07 | $0.79 | $0.79 |
| Income Tax Expense | $138000.00 | $174000.00 | $123000.00 | $61500.00 |
| Net Income | -$26.71M | -$15.26M | $78.12M | $39.06M |
| Net Income Ratio | -$1.07 | -$1.08 | $0.79 | $0.79 |
| EPS | -$2.34 | -$1.35 | $7.00 | $3.50 |
| Diluted EPS | -$2.34 | -$1.35 | $7.00 | $3.50 |
| Weighted Avg Shares Outstanding | $0.00 | $11.34M | $11.16M | $11.16M |
| Weighted Avg Shares Outstanding (Diluted) | $0.00 | $11.34M | $11.16M | $11.16M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan